Publications by authors named "Christine Huppertz"

11Publications

IκBζ is a key player in the antipsoriatic effects of secukinumab.

J Allergy Clin Immunol 2020 01 14;145(1):379-390. Epub 2019 Oct 14.

Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.

View Article and Find Full Text PDF
January 2020

Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells.

Immunol Lett 2017 12 24;192:48-51. Epub 2017 Oct 24.

Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address:

View Article and Find Full Text PDF
December 2017

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.

Immunity 2017 02;46(2):220-232

Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
February 2017

IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System.

Curr Drug Targets 2016 ;17(16):1882-1893

Novartis Institutes for Biomedical Research, WSJ 386.11.48.38, 4002, Basel, Switzerland.

View Article and Find Full Text PDF
August 2017

Low-molecular-weight MK2 inhibitors: a tough nut to crack!

Future Med Chem 2009 Oct;1(7):1243-57

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, CH-4056 Basel, Switzerland.

View Article and Find Full Text PDF
October 2009

Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity.

Bioorg Med Chem Lett 2008 Dec 11;18(23):6142-6. Epub 2008 Oct 11.

Novartis Institutes for BioMedical Research, global Discovery Chemistry, WSJ-88.508, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
December 2008